Products
Platform
Research
Market
Learn
Partner
Support
IPO

J

JHS Svendgaard Laboratories Share Price

10.12
-0.07 (-0.69%)
JHS • 16 Jan, 2026 | 03:29 PM

1Y Annualised Return

-49.55%

3Y Annualised Return

-21.30%

5Y Annualised Return

-13.87%

10Y Annualised Return

-9.90%

The current prices are delayed, login or Open Demat Account for live prices.

JHS Svendgaard Laboratories Stock Performance

1W Return-4.17
1Y Return-49.90
Today's Low10.03
Prev. Close10.19
Mkt Cap (Cr.)86.63
1M Return0.90
3Y Return-51.74
52-Week High21
Open10.21
PE Ratio0.00
6M Return-22.45
Today's High10.5
52-Week Low8.66
Face Value10

JHS Svendgaard Laboratories Company background

Founded in: 2004
JHS Svendgaard Laboratories Limited manufactures the entire range of oral care product at its ISOcertified state oftheart manufacturing facilities at Kala Amb (Himachal Pradesh). The Company was incorporated on October 8, 2004 in Himachal Pradesh by the Registrar of Companies, Punjab, Himachal Pradesh Chandigarh situated at Jalandhar with the main object to manufacture and or trade of/in dental/oral care products, which includes toothbrushes, toothpaste, tooth powder, mouth rinse, whitening gel, effervescent tablets, tongue cleaners etc. The company was promoted by Nikhil Nanda.Initially, they manufactured only toothbrushes but realizing the vast potential of the oral care market, they ventured into manufacturing of other dental care products like toothpastes, Mouthwash, Denture tablets etc. Some of the prominent brands with whom the Company has been associated with during its journey includes Amway India Enterprises Pvt. Ltd., Dabur India Limited, Patanjali Ayurved Limited, Hindustan Unilever Limited, Me N Moms Pvt. Ltd., Vestige Marketing Pvt. Ltd., Colgate Palmolive India Ltd., Elder Health Care Limited, J. L. Morisons India Limited,Dr. Fresh Inc., Boots, Lavoris, Walgreens, Walmart and many more recognized brands.In the year 2005, the company acquired the business from the three proprietary concerns namely Sunehari Svendgaard Laboratories, Sunehari Oral Care and Jai Hanuman Exports with effect from April 1, 2005. These three proprietary concerns became the three units of the company, namely Unit I SSL, Unit II SOC and Unit III JHE.In the year 2006, Unit IIIJHE was awarded the status of Star Export House (one Star) by the Government of India effective from April 1, 2005 to March 31, 2009.During the year 200607, the company increased the production capacity of Oral Care Products by 1.50 crore Pcs to 7.00 crore Pcs. In October 21, 2006, the company shares were listed on the Bombay Stock Exchange Ltd and the National Stock Exchange of India Ltd. In April 2, 2007, the company commenced the first phase of commercial Production at Kalaamb in Himachal Pradesh. In April 10, 2007, they acquired 9400 equity shares of Rs 10 each of Nikiven Personal Care Products Pvt Ltd NIKIVEN constituting 51.08% of the paidup capital. With this acquisition, Nikiven became a subsidiary of the company.During the year 200708, the company set up a 100% subsidiary company in Ras Al Khaimah Free Trade Zone, UAE with the name of Jones H Smith, FZE. In April 2008, they set up a subsidiary company with the name JHS Svendgaard Dental Care Ltd. During the year 200809, the company increased the production capacity of Oral Care Products by 13.02 crore Pcs to 24.62 crore Pcs. In February 4, 2009, they received the Best Performing Enterprise Award Runnerup (Turnover from Rs 26 to 100 crore) at Plasticon Awards 2009 for the oral care business with a Complete Range of Oral Care Products from The Plastindia Foundation. In April 2009, the company launched their own brand Dr. Gold, to use their experience in the oral care industry and encash the market opportunities.The Scheme of Amalgamation of M/s JHS Svendgaard Hygiene Products Limited and M/s Waves Hygiene Products (a Partnership Firm) with M/s JHS Svendgaard Laboratories had been approved by the Delhi High Court on 30th August, 2011 and by the Shimla High Court on 28 May, 2012. Resultantly, all the assets and liabilities of JHS Svendgaard Laboratories Limited (Transferor Company) and M/s. Waves Hygiene Products (Transferor Firm) was transferred to Company effective from 31 March, 2010, i.e. the Appointed Date.During 201718, M/s JHS Svendgaard Retail Ventures Pvt. Ltd. became the Subsidiary of the company with effect from April 13, 2018. JHS Svendgaard Brands Limited (formerly known as JHS Svendgaard Dental Care Limited) ceased to be Subsidiary of the Company w.e.f 01st September, 2020. During 202324, the Composite Scheme of Arrangement for Demerger of Retail Investment Division of the Company and vesting of the same with JHS Svendgaard Retail Ventures Private Limited on a going concern basis and immediately thereupon, amalgamation of JHS Svendgaard Brands Limited with the Company was effective w.e.f. 28 August, 2023.

JHS Svendgaard Laboratories Financial Highlights


For the full year FY2025–2026, revenue reached ₹94.87 crore and profit touched at ₹-19.74 crore.

JHS Svendgaard Laboratories Share Price Today


As of 18 Jan 2026, JHS Svendgaard Laboratories share price is ₹10.1. The stock opened at ₹10.2 and had closed at ₹10.2 the previous day. During today’s trading session, JHS Svendgaard Laboratories share price moved between ₹10.03 and ₹10.50, with an average price for the day of ₹10.27. Over the last 52 weeks, the stock has recorded a low of ₹8.66 and a high of ₹21.00. In terms of performance, JHS Svendgaard Laboratories share price has declined by 22.4% over the past six months and has declined by 49.55% over the last year.
Read More
JHS Svendgaard Laboratories SIP Return Calculator
5,000
Over the past
Total Investment of ₹0
Monthly SIP of 5,000 would have become 0 in 5 years with a gain of 0 (+0.00%)
View details of Market Depth

JHS Svendgaard Laboratories Fundamental

Market Cap (in crs)

86.63

Face Value

10

Turnover (in lacs)

4.20

Key Metrics

Qtr Change %
51.81% Fall from 52W High
-19.8
Dividend yield 1yr %
0

JHS Svendgaard Laboratories Key Financials

View more
Loading chart...
JHS Svendgaard Laboratories Quarterly Revenue
JHS Svendgaard Laboratories Yearly Revenue
JHS Svendgaard Laboratories Quarterly Net Profit/Loss
JHS Svendgaard Laboratories Yearly Net Profit/Loss

JHS Svendgaard Laboratories Result Highlights

  • JHS Svendgaard Laboratories Ltd reported a 4.2% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 14.0%.

  • Its expenses for the quarter were down by 1.7% QoQ and up 3.6% YoY.

  • The net profit decreased 118.9% QoQ and decreased 98.1% YoY.

  • The earnings per share (EPS) of JHS Svendgaard Laboratories Ltd - at - during Q2 FY 2025-26.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

JHS Svendgaard Laboratories Shareholding Pattern

Promoter
34.6%
Foreign Institutions
1.6%
Public
63.9%

JHS Svendgaard Laboratories Technical Analysis

Moving Averages Analysis
10.12
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
Day EMA5
10.30
Day EMA10
10.20
Day EMA12
10.20
Day EMA20
10.20
Day EMA26
10.20
Day EMA50
10.60
Day EMA100
11.20
Day EMA200
12.70
Delivery & Volume
Loading chart...

Day

69.10%

Week

53.30%

Month

54.00%

Delivery & Volume

10.22
Pivot
Resistance
First Resistance
10.40
Second Resistance
10.69
Third Resistance
10.87
Support
First Support
9.93
Second support
9.75
Third Support
9.46
Relative Strength Index
48.48
Money Flow Index
62.02
MACD
-0.05
MACD Signal
-0.15
Average True Range
0.84
Average Directional Index
14.19
Rate of Change (21)
0.90
Rate of Change (125)
-22.45
Compare

JHS Svendgaard Laboratories Latest News

12 JAN 2026 | Monday
26 DEC 2025 | Friday
22 DEC 2025 | Monday

Please be aware that JHS Svendgaard Laboratories stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account